Imatinib Capsule is a medicine that is used for the treatment of Blood Cancer, Gastrointestinal Stromal Tumors, Bone Marrow Cancer, Blood Cells Disorder, Hypereosinophilic Syndrome, Mast Cell Disease and other conditions.
Imatinib Capsule contains Imatinib Mesylate as an active ingredient.
Imatinib Capsule works by preventing cancer cells multiplication across the body.
Detailed information related to Imatinib Capsule's uses, composition, dosage, side effects and reviews is listed below.
Imatinib Capsule is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms:
· Blood Cancer
· Gastrointestinal Stromal Tumors
· Bone Marrow Cancer
· Blood Cells Disorder
· Hypereosinophilic Syndrome
· Mast Cell Disease
Imatinib Capsule improves the patient's condition by performing the following functions:
· Preventing cancer cells multiplication across the body.
Imatinib Capsule is composed of the following active ingredients (salts)
· Imatinib Mesylate
Please note that this medicine may be available in various strengths for each active ingredient listed above.
The following is a list of possible side-effects that may occur from all constituting ingredients of Imatinib Capsule. This is not a comprehensive list. These side-effects are possible, but do not always occur. Some of the side-effects may be rare but serious. Consult your doctor if you observe any of the following side-effects, especially if they do not go away.
· Swelling Due To Fluid Retention
· Blurred Vision
· Sore Throat
Before using this drug, inform your doctor about your current list of medications, over the counter products (e.g. vitamins, herbal supplements, etc.), allergies, pre-existing diseases, and current health conditions (e.g. pregnancy, upcoming surgery, etc.). Some health conditions may make you more susceptible to the side-effects of the drug. Take as directed by your doctor or follow the direction printed on the product insert. Dosage is based on your condition. Tell your doctor if your condition persists or worsens. Important counseling points are listed below.
· Cardiac disease or increased risk for congestive heart failure
· Do not drive or operate heavy machinery
· Do not give this drug to children without consultation
· Pregnant or planning to get pregnant
· Renal and hepatic impairment
The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:
Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.
Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.
North & South America: USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela , Brazil, Bahamas, Ecuador, etc .
Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.
OCEANIA: Australia, New Zealand, Fiji, etc.
Sorafenib Tosylate Tablets
Sunitinib Malate Capsules
Vincristine Sulphate Injection
Estramustine Phosphate Capsules
Tamoxifen Citrate Tablets
Zoledronic Acid Injection
Erythropoietin Prefilled Syringe Injection
Abiraterone Acetate Tablets
Vinblastine Sulphate Injection